New Key Statistics Module, Z-Score and F-Score
NAS:XBIO Key Ratios
Market Cap $ M | 6.10 |
Enterprise Value $ M | -2.09 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.70 |
Price/Sales | 2.47 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2.00 |
EPS (TTM) $ | -2.93 |
Beneish M-Score | -2.12 |
10-y EBITDA Growth Rate % | 35.10 |
5-y EBITDA Growth Rate % | 49.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.43 |
EV-to-EBITDA | 0.43 |
PEG | -- |
Shares Outstanding M | 1.54 |
Net Margin (%) | -182.99 |
Operating Margin % | -199.14 |
Pre-tax Margin (%) | -182.99 |
Quick Ratio | 11.70 |
Current Ratio | 11.70 |
ROA % (ttm) | -38.29 |
ROE % (ttm) | -41.35 |
ROIC % (ttm) | -470.89 |
Dividend Yield % | -- |
Altman Z-Score | -24.51 |
XBIO Number of Guru Trades
XBIO Volume of Guru Trades
Gurus Latest Trades with NAS:XBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:XBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Xenetic Biosciences Inc Insider Transactions
No Available Data
News about NAS:XBIO
Total 0- 1